Recent results have further demonstrated that SHP-2 binds and dephosphorylates both wild-type and oncogenic HRAS on Tyr32 in astrocytes and glioma cells, an event that increases RAS association with RAF-1 and downstream MEK/ERK activation [48]. This evidence concerns the gene MAPK1 and central nervous system cancer.